Bristol-Myers Squibb Company (BMYMP)

OTCMKTS · Delayed Price · Currency is USD · Preferred Stock
700.00
-80.50 (-10.31%)
Inactive · Last trade price on Mar 18, 2026
Market Cap120.95B
Revenue (ttm)48.30B
Net Income-8.95B
EPS-4.41
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividend2.00 (0.45%)
Ex-Dividend DateFeb 3, 2026
Volume13
Average Volume9
Open780.00
Previous Close780.50
Day's Range700.00 - 780.00
52-Week Range440.34 - 1,200.00
Betan/a
RSI29.03
Earnings DateApr 24, 2025

About BMYMP

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat ...

Industry Pharmaceutical Preparations
Founded 1887
Employees 32,500
Stock Exchange OTCMKTS
Ticker Symbol BMYMP